FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C difficile
Clinicians now have two approved options for recurrent infections after antibiotic treatment.
Source: medscape.com
Stay updated with breaking news from Large Intestinal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinicians now have two approved options for recurrent infections after antibiotic treatment.
A landmark trial suggests adding low-dose methotrexate should be strongly considered in children with Crohn's disease who are starting adalimumab.
The drug-free solution is designed for daily use. In a trial, the pill produced at least one additional weekly bowel movement for 41% of participants.